A Long-Term Extension Trial in Participants With Atopic Dermatitis Who Participated in Previous EDP1815 Trials
NCT05439941
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
287
Enrollment
INDUSTRY
Sponsor class
Stopped
Parent Study (NCT05121480) did not meet the primary endpoint.
Conditions
Atopic Dermatitis
Interventions
DRUG:
EDP1815
Sponsor
Evelo Biosciences, Inc.